readthroughSign in
CompanyVSTMNasdaqNeedham, MA

Verastem, Inc.

Verastem Oncology develops small molecule inhibitors targeting RAS/MAPK pathway-driven cancers.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 5Latest story